Table 2 Immunohistochemical expressions and TCR gene rearrangement of LL
From: Clinicopathological diagnosis of Lennert lymphoma: a case report and review of the literature
reference | Feller AC4 | Geissinger E10 | Hartmann S11 | WeisenburgerD15 | Kurita D9 |
|---|---|---|---|---|---|
Published year | 1986 | 2004 | 2011 | 2011 | 2016 |
CD2 | 4/4(100) | 10/18(56) | ND | 13/13(100) | UK |
CD3 | 4/4(100) | 18/18(100) | 8/8(100) | 14/16(88)♤ | 26/26(100) |
CD4 | 4/4(100)☆ | 1/18(6)☆ | N/A | 9/14(64) | 22/26(85) |
CD5 | 4/4(100) | 17/18(94) | UK | 13/15(87) | UK |
CD8 | 0/4(0)☆ | 16/18(89)☆ | 3/8(38) | 7/16(44) | 5/26(19) |
CD30Δ | ND | 2/18(12) | 5/8(63) | 2/16(13) | UK |
CD56 | ND | 0/18(0) | ND | 1/13(8) | UK |
TIA-1 | N/A | N/A(53) | 6/8(75) | 6/13(46) | 4/26(15) |
GrB | N/A | N/A(35) | 0/8(0) | UK | 0/26(0) |
TFH markers◇ | ND | ND | 0/8(0) | UK | 15/26(58) |
EBER | ND | ND | 0/8(0) | 4/13(31) | 8/26(31) |
Ki67 | 10-30% | UK | 5-40% | UK | UK |
TCRβ | 4/4(100)※ | UK | 8/8(100) | 10/11(91) | 10/13(77)※ |